Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
INBX Inhibrx Biosciences Inc reports narrow Q4 2025 EPS beat shares rise 616 percent on upbeat investor sentiment SiNtx Technologies SINT Stock Buy Sell Hold 037 20260418 Why Appian APPN could be the turning point youve been waiting for 774 20260508 What LPL LPLA is doing that smart money tracks Underperforming 20260511 State Street SPDR SP Biotech ETF XBI Investment Case Assessment and Sector Positioning Analysis GOODN Gladstone Q1 2026 earnings beat estimates by 569 delivering EPS of 008 vs 0051 forecast What XXxs fundamentals reveal about its future 099 20260511 James Bank BOTJ Q1 2025 Earnings Revenue NA Matching Views SP 500 Dow Futures Slide Up to 08 as Oil Prices Stay Elevated Brent Reaches 112 IranianLinked Tankers Exploit Maritime Gaps in 42 Oil Transfers Off Malaysia Report Says GCL Global GCLWW Stock Today Unchanged at 002 Key Levels 20260517 Should You Sell Inovio Pharmaceuticals INO After 368 Drop 20260515 Neuraxis NRXS Drops 457 Key Support at 713 20260518 WWE Saturday Nights Main Event Potential Viewership and Revenue Implications for TKO Group Holdings UK Government Announces 120m Support Package for Ceramics Industry George Soross Fund Makes Major Bet on Talkspace Stock Market Digest Lowes Aptiv Zoetis in Focus Workday Surges on Upgraded Margin Outlook AI Adoption Cited by CEO Stellantis Refocuses on Jeep Ram Peugeot and Fiat in Major Strategic Overhaul PCOR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower Sera Prognostics Q1 2026 Earnings InLine Loss and No Revenue as Stock Surges on Pipeline Progress SVRA Q1 2026 Earnings EPS Misses Estimates Stock Declines Amid Lack of Revenue AIHS Q1 2026 Earnings Reported Net Loss Persists Amidst Operational Challenges LiveWire Group Inc LVWR Q1 2026 Earnings Narrowing Loss Amid Strategic Transition CHMG Q1 2026 Earnings Strong EPS Beat Driven by Core Banking Strength K2 Capital Acquisition Corporation Rights KTWOR Hold Steady at 022 Amid Low Volume PROCEPT BioRobotics PRCT Slips 36 as Selling Pressure Tests Key Support STAK Inc STAK Holds Steady Near 096 as Bulls Test Resistance Revolve Group Inc RVLV Inches Higher as Stock Approaches Key Resistance Zone Tenaya Therapeutics TNYA Edge Higher SmallCap Biotech Tests Key Resistance at 083